EE05459B1 - Sporogeense Bacillus smithii tvi TBMI12 MSCL P737 ja selle endospooride kasutamine probiootikumina, toidulisandina ning probiootiline kompositsioon - Google Patents

Sporogeense Bacillus smithii tvi TBMI12 MSCL P737 ja selle endospooride kasutamine probiootikumina, toidulisandina ning probiootiline kompositsioon

Info

Publication number
EE05459B1
EE05459B1 EEP200600038A EEP200600038A EE05459B1 EE 05459 B1 EE05459 B1 EE 05459B1 EE P200600038 A EEP200600038 A EE P200600038A EE P200600038 A EEP200600038 A EE P200600038A EE 05459 B1 EE05459 B1 EE 05459B1
Authority
EE
Estonia
Prior art keywords
probiotic
endospores
sporogenic
nutritional supplement
bacillus smithii
Prior art date
Application number
EEP200600038A
Other languages
English (en)
Inventor
J?Gi Eerik
Nurk Allan
Suitso Indrek
Talpsep Ene
Naaber Paul
L?ivukene Krista
Original Assignee
Tartu �likool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tartu �likool filed Critical Tartu �likool
Priority to EEP200600038A priority Critical patent/EE05459B1/et
Priority to RU2009126450/10A priority patent/RU2439145C2/ru
Priority to AT07817985T priority patent/ATE533499T1/de
Priority to ES07817985T priority patent/ES2374082T3/es
Priority to PCT/EE2007/000021 priority patent/WO2008067827A1/en
Priority to UAA200906956A priority patent/UA99450C2/ru
Priority to EP07817985A priority patent/EP2101796B1/en
Priority to DK07817985.0T priority patent/DK2101796T3/da
Publication of EE200600038A publication Critical patent/EE200600038A/et
Publication of EE05459B1 publication Critical patent/EE05459B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200600038A 2006-12-08 2006-12-08 Sporogeense Bacillus smithii tvi TBMI12 MSCL P737 ja selle endospooride kasutamine probiootikumina, toidulisandina ning probiootiline kompositsioon EE05459B1 (et)

Priority Applications (8)

Application Number Priority Date Filing Date Title
EEP200600038A EE05459B1 (et) 2006-12-08 2006-12-08 Sporogeense Bacillus smithii tvi TBMI12 MSCL P737 ja selle endospooride kasutamine probiootikumina, toidulisandina ning probiootiline kompositsioon
RU2009126450/10A RU2439145C2 (ru) 2006-12-08 2007-10-08 Штамм микроорганизма bacillus smithii tbmi12 mscl p737 и применение его в качестве пищевой или кормовой добавки, или компонента пробиотической композиции и пробиотическая композиция
AT07817985T ATE533499T1 (de) 2006-12-08 2007-10-08 Bacillus smithii-stamm tbmi12 mscl p737 und verwendung von endosporen davon als probiotisches mittel oder nahrungszusatz
ES07817985T ES2374082T3 (es) 2006-12-08 2007-10-08 Cepa de bacillus smithii tbmi 12 mscl p737 y uso de endosporas de la misma con un probiótico o un suplemento alimentario.
PCT/EE2007/000021 WO2008067827A1 (en) 2006-12-08 2007-10-08 Bacillus smithii strain tbmi12 mscl p737 and use of endospores thereof as a probiotic or a food supplement
UAA200906956A UA99450C2 (ru) 2006-12-08 2007-10-08 Штамм микроорганизма bacillus smithii tbmi12 mscl p737 и его функциональные эквиваленты (эндоспоры, мутанты, поколения, производные) для защиты от действия энтеропатогенных бактерий
EP07817985A EP2101796B1 (en) 2006-12-08 2007-10-08 Bacillus smithii strain tbmi12 mscl p737 and use of endospores thereof as a probiotic or a food supplement
DK07817985.0T DK2101796T3 (da) 2006-12-08 2007-10-08 Bacillus smithii stamme TBM112 MSCL P737 og anvendelse af endosporer deraf som probiotikum eller kosttilskud

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EEP200600038A EE05459B1 (et) 2006-12-08 2006-12-08 Sporogeense Bacillus smithii tvi TBMI12 MSCL P737 ja selle endospooride kasutamine probiootikumina, toidulisandina ning probiootiline kompositsioon

Publications (2)

Publication Number Publication Date
EE200600038A EE200600038A (et) 2008-08-15
EE05459B1 true EE05459B1 (et) 2011-08-15

Family

ID=38921740

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200600038A EE05459B1 (et) 2006-12-08 2006-12-08 Sporogeense Bacillus smithii tvi TBMI12 MSCL P737 ja selle endospooride kasutamine probiootikumina, toidulisandina ning probiootiline kompositsioon

Country Status (8)

Country Link
EP (1) EP2101796B1 (et)
AT (1) ATE533499T1 (et)
DK (1) DK2101796T3 (et)
EE (1) EE05459B1 (et)
ES (1) ES2374082T3 (et)
RU (1) RU2439145C2 (et)
UA (1) UA99450C2 (et)
WO (1) WO2008067827A1 (et)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2509149C1 (ru) * 2012-08-31 2014-03-10 Общество с ограниченной ответственностью "НОВА" ШТАММ Bacillus subtilis subsp. Subtilis ВКМ В-2711D, ОБЛАДАЮЩИЙ ВЫРАЖЕННЫМ АНТАГОНИЗМОМ ПО ОТНОШЕНИЮ К Escherichia coli, Salmonella typhi, Staphylococcus aureus, Listeria monocytogenes И РЕЗИСТЕНТНОСТЬЮ К СТРЕПТОМИЦИНУ И ТЕТРАЦИКЛИНУ
BR112015011933A8 (pt) * 2012-11-23 2022-09-20 Seres Therapeutics Inc Composições bacterianas sinérgicas e métodos de produção e uso das mesmas
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
WO2014121304A1 (en) 2013-02-04 2014-08-07 Seres Health, Inc. Compositions and methods
KR102222273B1 (ko) 2013-02-04 2021-03-08 세레스 테라퓨틱스, 인코포레이티드 조성물 및 방법
US10076546B2 (en) 2013-03-15 2018-09-18 Seres Therapeutics, Inc. Network-based microbial compositions and methods
MX367109B (es) 2013-11-25 2019-08-05 Seres Therapeutics Inc Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
US9956282B2 (en) 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
RS57471B1 (sr) 2015-12-17 2018-09-28 Institut Za Molekularnu Genetiku I Geneticko Inzenjerstvo Univerzitet U Beogradu Nova probiotička starter kultura za humanu i animalnu primenu
EP3668527A1 (en) 2017-08-14 2020-06-24 Seres Therapeutics, Inc. Compositions and methods for treating cholestatic disease
CN114410514B (zh) * 2021-12-31 2024-04-02 上海新溢生物科技工程研究中心(有限合伙) 斯密氏芽孢杆菌及其用途

Also Published As

Publication number Publication date
UA99450C2 (ru) 2012-08-27
ES2374082T3 (es) 2012-02-13
RU2439145C2 (ru) 2012-01-10
DK2101796T3 (da) 2012-02-13
EE200600038A (et) 2008-08-15
ATE533499T1 (de) 2011-12-15
EP2101796B1 (en) 2011-11-16
RU2009126450A (ru) 2011-01-20
EP2101796A1 (en) 2009-09-23
WO2008067827A1 (en) 2008-06-12

Similar Documents

Publication Publication Date Title
EE05459B1 (et) Sporogeense Bacillus smithii tvi TBMI12 MSCL P737 ja selle endospooride kasutamine probiootikumina, toidulisandina ning probiootiline kompositsioon
BRPI1010637A2 (pt) suplementos nutricionais orais compreendendo probióticos
MY151204A (en) Lactobacillus plantarum and uses thereof
EP4257194A3 (en) Use of microbial communities for human and animal health
NZ593708A (en) Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
WO2008117266A3 (en) Probiotic bifidobacterium strains
PL1874917T3 (pl) Kompozycja probiotyczna odpowiednia dla zwierząt
MY146595A (en) Probiotic bifidobacterium strains
NZ592154A (en) Method for using bacillus subtilis qst713 to enhance animal health
DK1855550T3 (da) Næringspræparat med probiotika
WO2008153655A3 (en) Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic fhv-1 infections, and preventing or treating conjunctivitis
MX2012005524A (es) Cepa de probioticos bifidobacterium.
PL2173196T3 (pl) Zastosowanie probiotyków i włókien w biegunce
MX2008006546A (es) Bifidobacteria productora de ácido fólico, composición alimenticia y uso de la bifidobacteria.
WO2005112976A3 (en) Probiotic compounds from lactobacillus gg and uses therefor
DK1624762T3 (da) Probiotisk præparat med mindst to mælkesyrebakteriestammer som er i stand til kolonisere mavetarmkanalen, i kombination med at de besidder overlevelsesegenskab, tarmbindende egenskab, en infektionsbeskyttelsesegenskab og en fiberfermenterende egenskab
UA94056C2 (uk) Застосування специфічних молочнокислих бактерій для одержання імуномодулюючих композицій
ATE531380T1 (de) Probiotischer futtermittel- und/oder trinkwasserzusatz und verwendung
WO2006046871A3 (en) Peri-operative composition comprising lactobacillus rhamnosus
EP1607096A3 (en) Nutraceutical composition containing milk enzymes useful as synbiotic
EP3318625A3 (en) A lactic acid bacteria strain
WO2006104388A3 (en) Novel probiotic
WO2008143527A8 (en) Probiotic bacterium
UA38395U (ru) Препарат комплексный пробиотически-сорбционный для коррекции дисбиотических нарушений у мелких животных "сорбелакт"
Lavryk Characteristics of adhesive properties of lactobacillus-clinical isolates and components of biological products

Legal Events

Date Code Title Description
MM4A Lapsed by not paying the annual fees

Effective date: 20121208